Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
J Aron-Wisnewsky, C Vigliotti, J Witjes, P Le… - Nature Reviews …, 2020 - nature.com
Gut microbiota dysbiosis has been repeatedly observed in obesity and type 2 diabetes
mellitus, two metabolic diseases strongly intertwined with non-alcoholic fatty liver disease …
mellitus, two metabolic diseases strongly intertwined with non-alcoholic fatty liver disease …
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice
Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of
chronic liver disease, and its prevalence is rising worldwide. The occurrence of non …
chronic liver disease, and its prevalence is rising worldwide. The occurrence of non …
[HTML][HTML] Liver fibrosis in non-alcoholic fatty liver disease-diagnostic challenge with prognostic significance
P Stål - World Journal of Gastroenterology: WJG, 2015 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western
world, with a prevalence of 20%. In a subgroup of patients, inflammation, ballooning …
world, with a prevalence of 20%. In a subgroup of patients, inflammation, ballooning …
[HTML][HTML] Current status of imaging in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver disease, with a
worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and …
worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and …
[HTML][HTML] Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study
S Fresneda, M Abbate, C Busquets-Cortés… - Biology of sex …, 2022 - Springer
Background Despite the extensive scientific evidence accumulating on the epidemiological
risk factors for non-alcoholic fatty liver disease (NAFLD), evidence exploring sex-and age …
risk factors for non-alcoholic fatty liver disease (NAFLD), evidence exploring sex-and age …
Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus
F Bril, K Cusi - Endocrinology and Metabolism Clinics, 2016 - endo.theclinics.com
Nonalcoholic fatty liver disease (NAFLD) is defined as the presence of hepatic steatosis (>
5% of hepatocytes by histology or> 5.6% by nuclear magnetic resonance techniques) in the …
5% of hepatocytes by histology or> 5.6% by nuclear magnetic resonance techniques) in the …
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome
D Macut, K Tziomalos, I Božić-Antić… - Human …, 2016 - academic.oup.com
STUDY QUESTION What are the most relevant factors associated with non-alcoholic fatty
liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)? SUMMARY …
liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)? SUMMARY …
Poor performance of non-invasive tests for advanced fibrosis in nonalcoholic fatty liver disease: a multicentric Asian study
U Arora, RM Goyal, KKJ Teh, Y Pei, GBB Goh… - Digestive Diseases and …, 2023 - Springer
Abstract Background Non-invasive tests (NITs) are useful to assess advanced fibrosis (AF)
in nonalcoholic fatty liver disease (NAFLD). Data from Asian countries suggest that these …
in nonalcoholic fatty liver disease (NAFLD). Data from Asian countries suggest that these …
Thyroid hormone receptor-β agonists in NAFLD therapy: possibilities and challenges
L Li, Y Song, Y Shi, L Sun - The Journal of Clinical …, 2023 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) is a progressive metabolic liver disease with an
unknown pathogenesis and no FDA-approved drug treatment to date. Hypothyroidism has …
unknown pathogenesis and no FDA-approved drug treatment to date. Hypothyroidism has …
[HTML][HTML] MAFLD/NAFLD biopsy-free scoring systems for hepatic steatosis, NASH, and fibrosis diagnosis
NÁ Segura-Azuara, CD Varela-Chinchilla… - Frontiers in …, 2022 - frontiersin.org
Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as
nonalcoholic fatty liver disease, is the most prevalent liver disorder worldwide. Historically …
nonalcoholic fatty liver disease, is the most prevalent liver disorder worldwide. Historically …